The Paxman Scalp Cooling System is a mobile refrigeration unit which circulates a specially developed coolant through the system and into a cap attached to the system. It has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The system is available for either single or dual patient use and the caps are available in a range of sizes to ensure optimum fit for the patient. The system is used whilst the patient is undergoing chemotherapy treatment and the cap is worn for a period of time before, during and after chemotherapy drug infusion. Chemotherapy Induced Hairloss (CIA) compromises patient quality of life, can negatively impact on body image, self-esteem and deprive patients of their privacy. Sometimes, the prospect of CIA can cause patients to refuse treatment. Scalp cooling is proven to be an effective way of combatting CIA and can result in a high level of retention or completely preserve the hair. For patients, this means the opportunity to regain some control, maintain privacy and encourage a positive attitude towards treatment. Investing in scientific testing and development has allowed us to attain the highest levels of technical precision and clinical efficacy of our cold cap. Paxman now have over 3,000 systems worldwide and are the leading manufacturer in scalp cooling technology.